NCT06209476View on ClinicalTrials.gov

Clinical Investigation on Assessing the Repeatability and Reproducibility of Central and Peripheral Refractive Error

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 16, 2024

Primary Completion Date

February 5, 2024

Study Completion Date

February 5, 2024

Conditions
Refractive Error
Interventions
DIAGNOSTIC_TEST

Experimental

Eligible subjects with sphere component of the subjective spherocylindrical refraction between +1.50 to -6.00D (inclusive) and 2.00D or less astigmatism in the right eye will be unilaterally measured with the WAM-5500 autorefractor by 3 testers.

Trial Locations (1)

32256

VRC, Jacksonville

All Listed Sponsors
lead

Johnson & Johnson Vision Care, Inc.

INDUSTRY

NCT06209476 - Clinical Investigation on Assessing the Repeatability and Reproducibility of Central and Peripheral Refractive Error | Biotech Hunter | Biotech Hunter